ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener 🦋 Butterfly 8 Analysts 🏛️ Policy 🎬 Video ★ Watchlist 🎲 Prediction Markets 📊 RQD Track Record 📅 Next Catalysts 🛡️ Overlap & Crash X-Ray 📰 Live Wire 🐋 13F Whales 🏛️ Congress & CEO Buys 🏆 $100K Arena ⌘ Pro Terminal 📐 Methodology & Corrections
Stock Ratings / Financials / BCAT / insiders
ECAT (41) KYN (58) BTZ (43) BCX (45) ⌘ Pro Terminal →

BlackRock Capital Allocation Term Trust of (BCAT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$13.79 -0.14% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.76

BlackRock Capital Allocation Term Trust of (BCAT) carries a Roarable Rating of D (Sell) with 44/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (44/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →
ROARABLE D • SELL / AVOID Cap $1.49B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BCAT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BCAT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, BlackRock Capital Allocation Term Trust of (NYSE: BCAT) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 44/100 at a spot price of $13.79 (-0.14% 1D, market cap $1.49B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, BCAT ranks #820 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BCAT compare to ECAT and KYN in the Financials sector?
▼

Within the Financials sector (Finance/Investors Services), BCAT carries a Roarable D (44/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, ECAT (BlackRock ESG Capital Allocation Term Trust of) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $1.46B) and KYN (Kayne Anderson Energy Infrastructure Fund Inc.) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $2.02B). Among the 5-stock peer group, BCAT leads on earnings multiple (N/A) while BCAT leads on capital efficiency (— ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BCAT?
▼

For BlackRock Capital Allocation Term Trust of (BCAT), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #820 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $13.76 (-0.22%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 1% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (44/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510044
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D
Cash (11)Whales (6)SEC (13)Macro (5)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-6.3% Base Target
$17 Bull$13 Base$10 Bear
📬 FREE BCAT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BCAT)Realized 20D OHLCV Swing Band: ±3.4%
Deterministic 5-Pillar Attribution (44/100 Composite)
🔍 WHY BCAT SCORES 44/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+11/20 pts (25% of score)

SEC XBRL Trailing 12 Months: 1% FCF Margin ($41.8M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Macro Regime Fit5/20 pts (-15 pt drag)

Macro rate sensitivity & RSI-14 (52.3) create a -15 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
36
Grade E$13.66-2.6% Next Q
Q2 (-2Q)
39
Grade E$13.31+0.8% Next Q
Q3 (-1Q)
41
Grade D$13.42+2.8% Next Q
Current
44
Grade D$13.79-6.5% Hist 90D α
Trajectory: E (36) → D (44)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BCAT Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BCAT currently carries a cautious 44/100 (D) rating due to Macro Regime Fit (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($14.26) and Max Pain ($14.48) forces dealer call-delta covering toward $17.01.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BCAT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BCAT Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
YES 44%NO 56%Trade / Inspect Odds →
SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

BCAT Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING

Explore All 13F & Congress Whales →
▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (BCAT)

No recent open-market Form 4 cluster sales or emergency dumps flagged on BCAT. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BCAT)

  • ✓Walkthrough of BCAT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
BCAT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -9.69%📐 HORIZONTAL RANGE
2026-11-03O $13.81H $13.81L $13.79C $13.79VOL 709.2K
RES: $16.24SUP: $12.58SMA50: $14.26SMA200: $15.02
$16.43$15.48$14.52$13.57$12.61RES $16.24SUP $12.58$13.792026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BCAT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BCAT Butterfly Map → + Track BCAT →
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BCAT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BCAT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BCAT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BCAT)

Financials Rank #820 of 1096 ⚔️ ECAT vs BCAT Full Matrix →

1. Head-to-Head Financials Peer Comparison (BCAT vs. ECAT, KYN, BTZ, BCX)

Industry: Finance/Investors Services (37 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, BlackRock Capital Allocation Term Trust of (BCAT) ranks #820 by composite RQD confidence (44/100, grade D) and #484 by equity capitalization ($1.49B). Within this direct 5-issuer industry benchmark cohort, BCAT leads on earnings valuation at N/A trailing P/E, while BCAT leads on capital efficiency and profitability with — ROIC and — gross margin. KYN currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with BCAT at 44/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BCAT ACTIVE
BlackRock Capital Allocation Term Trust of
D 44/100 — — — -0.14% $1.49B Benchmark Subject
ECAT
BlackRock ESG Capital Allocation Term Trust of
D- 41/100 — — — -1.17% $1.46B /ecat-vs-bcat →
KYN
Kayne Anderson Energy Infrastructure Fund Inc.
D+ 58/100 — — — +0.95% $2.02B /kyn-vs-bcat →
BTZ
BlackRock Credit Allocation Income Trust
D- 43/100 — — — -1.04% $1.03B /btz-vs-bcat →
BCX
BlackRock Resources of
D 45/100 — — — -0.91% $1.01B /bcx-vs-bcat →

2. BCAT Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

BlackRock Capital Allocation Term Trust of (BCAT) operates in Finance/Investors Services (Financials) with an equity capitalization of $1.49B, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. BCAT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BCAT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, BlackRock Capital Allocation Term Trust of (NYSE: BCAT) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 44/100 at a spot price of $13.79 (-0.14% 1D, market cap $1.49B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, BCAT ranks #820 in composite RQD confidence.

How does BCAT compare to ECAT and KYN in the Financials sector?

Within the Financials sector (Finance/Investors Services), BCAT carries a Roarable D (44/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, ECAT (BlackRock ESG Capital Allocation Term Trust of) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $1.46B) and KYN (Kayne Anderson Energy Infrastructure Fund Inc.) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $2.02B). Among the 5-stock peer group, BCAT leads on earnings multiple (N/A) while BCAT leads on capital efficiency (— ROIC).

What are the biggest fundamental strengths and SEC risk factors for BCAT?

For BlackRock Capital Allocation Term Trust of (BCAT), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #820 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BCAT trading relative to its 50-day, 200-day, and 52-week technical levels?

BCAT last traded at $13.79 (-0.14% on volume of 709,212 shares), positioning the stock -3.30% below its 50-day simple moving average ($14.26) and -8.19% below its 200-day simple moving average ($15.02). Across its 52-week range of $12.91 to $16.20, BCAT sits at the 26.7% percentile with a 14-day RSI of 52.3 (NEUTRAL RANGE) and an implied next-earnings move of ±3.4% ($13.32 to $14.26).

BCAT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are BCAT insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies BCAT leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.

Direct Sub-Reports: BCAT RQD Cockpit BCAT 12M Forecast BCAT Earnings & Move BCAT Dividends & DRIP BCAT Insiders & 13F BCAT Whale Options BCAT Profit Sankey BCAT News & Why
ROARABLE RATING BRIEF • RQD 44/100 (D) ✓ STAGE-C NUMBER FIREWALL VERIFIED

BCAT — BlackRock Capital Allocation Term Trust of: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T14:13:33Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, BCAT scores 44 out of 100, graded D, with the verdict "Roarable Sell — Underperform / Distribution Warning." The five pillars are: Fundamental Cash Engine at 11/20 (ROIC 0%; FCF yield 0%), Whale 13F Flow at 6/20 (institutional accumulation and options positioning), Insider Conviction at 9/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 5/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 13/20 (Altman Z 2.5; Piotroski F 6/9; Debt/Equity 0.5).

For a prospective investor, the weakest pillars are the cash engine and macro fit. A 0% ROIC and 0% FCF yield, per the market data section, mean the source data shows no measurable cash return on capital in the metrics provided, so any upside case rests on price movement rather than demonstrated cash generation. The balance sheet pillar is the relative strength: a Piotroski F of 6/9 and Altman Z of 2.5 are the most constructive datapoints in the rating, and a Debt/Equity of 0.5 suggests moderate leverage. Institutional and insider pillars sit in the middle-to-low range, indicating no strong conviction signal in either direction. The overall implication is that the rating frames BCAT as a name where risk-adjusted support is thin, and valuation tradeoffs cannot be assessed fully because earnings-based multiples are unavailable in the source data.

Recent Catalysts & News Wire Analysis

Per the recent news section, the single catalyst item is a Stock Traders Daily piece titled "Why (BCAT) Price Action Is Critical for Tactical Trading," published 1h ago and tagged with a YELLOW light and a MARKET WIRE impact label. The summary describes coverage of market action, institutional positioning, and fundamental catalysts, but the article body is not provided, so no specific catalyst, earnings event, or position change can be confirmed. Risk watch items cannot be identified beyond the rating's own pillar weaknesses. Per the butterfly supply-chain graph, there are no proprietary signals and no butterfly links.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals. Upstream and downstream dependencies, sector correlations, and 2nd-order bottlenecks cannot be mapped from the supplied data. The only sector context available is the Financials / Finance/Investors Services classification and the beta of 1.0, which implies market-level sensitivity but does not identify specific ripple pathways.

Open Questions

  • What are BCAT's reported revenue, operating income, net income, and free cash flow across recent periods, given that the financials section is empty?
  • Why does the market data show 0% for margins, ROIC, and FCF yield, and does that reflect true economics or missing source fields?
  • What is the analyst consensus rating and price target, and how does the current $13.81 price compare to the 52-week range?
  • Who are the institutional and insider holders driving the Whale and Insider pillar scores, and what is the direction and size of recent activity?
  • What does the Stock Traders Daily article actually say about BCAT's catalysts, and is there any scheduled event that could move the stock?

BCAT Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for BlackRock Capital Allocation Term Trust of (BCAT) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BCAT Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BCAT Bull vs. Bear Conversation Board — What's Your Call at $13.79?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BCAT 🐻 67% BEARISH CONVICTION
1. Pick Your Side on BCAT:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $12.15 (-12.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is BCAT (D • RQD 44/100) a Buy at $13.81?

Welcome to the BCAT (BlackRock Capital Allocation Term Trust of) Roar Pit. Current RQD Composite is 44/100 (Roarable Sell — Underperform / Distribution Warning) in Finance/Investors Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

FO ForensicBear Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $11.32 (-18.0%)
Spot @ $13.81

Pump the brakes on BCAT — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on BCAT, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless BlackRock Capital Allocation Term Trust of expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader 🐂 BULLISH 🎯 Target: $17.40 (+26.0%)
Spot @ $13.81

BCAT cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on BCAT, the market is fixating on short-term headline noise in Finance/Investors Services and ignoring the balance sheet and cash flow trajectory. At $13.81 (52-wk range $12.91 - $16.20), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%